From Globe Newswire: 2025-04-14 12:30:00

Nexalin Technology, Inc. has recently been granted a patent by the USPTO for its Alternating Current Dynamic Frequency Stimulation Method for Opioid Use Disorder and Substance Use Disorder. This non-invasive DIFS™ technology aims to help individuals struggling with substance use disorders by regulating neural pathways linked to addiction and withdrawal symptoms. With millions affected by substance use disorders globally, Nexalin’s technology offers a drug-free alternative to traditional treatments, potentially easing withdrawal symptoms and supporting long-term recovery. The Company’s commitment to innovative, non-invasive solutions for addiction and mental health treatment is highlighted by this recent patent approval.



Read more at Globe Newswire: Nexalin Technology Secures USPTO Patent for Deep